Associations between omega-3 fatty acids and insulin resistance and body composition in women with polycystic ovary syndrome
Open accessThe DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Abstract
Background: Polycystic ovary syndrome (PCOS) is strongly associated with abdominal obesity and insulin resistance and effective approaches to nutrition (e.g., omega-3 fatty acids intake) might improve the cardiometabolic risk profile. This study aimed to examine the associations of dietary and serum omega-3 fatty acids with insulin resistance (IR) and body composition among PCOS patients. Methods: A total of 185 patients with PCOS were included in our analysis. Dietary information was collected through face-to-face interviews using a 102-item food frequency questionnaire (FFQ). Serum omega-3 fatty acid levels were measured with the gas chromatography method. Body composition was measured by both dual-energy X-ray absorptiometry (DXA) and bioelectrical impedance (BIA) methods. The multivariable linear regression model was applied to analyze the associations of dietary and serum omega-3 fatty acids with the levels of Homeostasis Model Assessment for Insulin Resistance (HOMA-IR) and body composition parameters among PCOS patients. Results: Our results indicated that the dietary long-chain omega-3 polyunsaturated fatty acids (PUFA) intakes were negatively associated with HOMA-IR (β = –0.089, P = 0.040), fat mass (β = –0.022, P = 0.047), and body fat percentage (β = –0.026, P = 0.032). For serum biomarkers, higher total omega-3 PUFAs levels (β = –0.158, P = 0.021) and long-chain omega-3 PUFAs levels (β = –0.187, P < 0.001), particularly eicosapentaenoic acid (EPA) (β = –164, P = 0.011) and docosahexaenoic acid (DHA) (β = –0.158, P = 0.001) were also associated with decreased HOMA-IR. In addition, generally, dietary and serum long-chain omega-3 PUFA levels, DPA, and DHA levels were both positively associated with muscle mass measured by DXA; whereas serum total, long-chain and individual omega-3 PUFA levels (e.g., DPA, EPA, and DHA) were all negatively associated with fat mass and body fat percentage. These findings were further confirmed by the findings for body composition measured by the BIA method. Conclusion: Higher levels of dietary and serum omega-3 PUFAs, particularly long-chain omega PUFAs (DPA and DHA), might have beneficial effects on metabolic parameters and body composition among PCOS patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Another cross-sectional study, which included 185 women with PCOS from China, found that both dietary n-3 PUFA intake as well as serum n-3 PUFA, especially EPA and DHA levels, were negatively correlated with HOMA-IR index and body fat levels [63]”
From Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome (2024) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Oh, D. Y., Talukdar, S., Bae, E. J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W. J., Watkins, S. M., & Olefsky, J. M. (2010) · Cell · doi:10.1016/j.cell.2010.07.041 · Cited by 2,428 · cited 3×
“An omega-3 fatty acids treatment could effectively enhance systemic insulin sensitivity in mice by up-regulating the function of G protein-coupled receptor 120 (GPR120) (19).”
Dumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020
Rojas, J., Chávez, M., Olivar, L., Rojas, M., Morillo, J., Mejías, J., Calvo, M., & Bermúdez, V. (2014) · International Journal of Reproductive Medicine · doi:10.1155/2014/719050 · Cited by 467
Omega-3 fatty acids and metabolic syndrome: Effects and emerging mechanisms of action
Poudyal, H., Panchal, S. K., Diwan, V., & Brown, L. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.003 · Cited by 370
Omega-3 fatty acids in obesity and metabolic syndrome: A mechanistic update
Albracht-Schulte, K., Kalupahana, N. S., Ramalingam, L., Wang, S., Rahman, S. M., Robert-McComb, J., & Moustaid-Moussa, N. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.02.012 · Cited by 355
[A description on the Chinese national nutrition and health survey in 2002].
Li, L.-M., Rao, K.-Q., Kong, L., Yao, C., Hong-ding, X., Zhai, F., Ma, G., & Yang, X. (2005) · Zhonghua liuxingbingxue zazhi · Cited by 250
Lipid modulation of skeletal muscle mass and function
Lipina, C., & Hundal, H. S. (2017) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12144 · Cited by 247
New Approach to Polycystic Ovary Syndrome and Other Forms of Anovulatory Infertility
Laven, J. S. E., Imani, B., Eijkemans, M. J. C., & Fauser, B. C. J. M. (2002) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-200211000-00022 · Cited by 235 · cited 1×
“Characterized by a series of manifestations of hyperandrogenemia, persistent anovulation, and ovarian polycystic changes (1), polycystic ovary syndrome (PCOS) is one of the most common endocrine-metabolic disorders that affects 5 to 10% of women of reproductive age (2).”
BackgroundFarrell, K., & Antoni, M. H. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.03.081 · Cited by 209
Schulze, M. B., Minihane, A. M., Saleh, R. N. M., & Risérus, U. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30148-0 · Cited by 197
Environmental determinants of polycystic ovary syndrome
Merkin, S. S., Phy, J. L., Sites, C. K., & Yang, D. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.05.011 · Cited by 193
n-3 Polyunsaturated fatty acids prevent the defect of insulin receptor signaling in muscle
Taouis, M., Dagou, C., Ster, C., Durand, G., Pinault, M., & Delarue, J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00320.2001 · Cited by 181
Effect of Diet on Insulin Resistance in Polycystic Ovary Syndrome
Shang, Y., Zhou, H., Hu, M., & Feng, H. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa425 · Cited by 171 · cited 1×
“Diet is an effective, acceptable, and safe intervention for relieving IR (29).”
BackgroundNutritional management in women with polycystic ovary syndrome: A review study.
Faghfoori, Z., Fazelian, S., Shadnoush, M., & Goodarzi, R. (2017) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2017.03.030 · Cited by 153
Insulin-sensitizing effects of omega-3 fatty acids: lost in translation?
Lalia, A., & Lanza, I. (2016) · Nutrients · doi:10.3390/nu8060329 · Cited by 141 · cited 1×
“, IL10, MGL1, YM-1) in adipose tissue (37).”
Fish or n3‐PUFA intake and body composition: a systematic review and meta‐analysis
Bender, N., Portmann, M., Heg, Z., Hofmann, K., Zwahlen, M., & Egger, M. (2014) · Obesity Reviews · doi:10.1111/obr.12189 · Cited by 137
Lanza, I. R., Blachnio-Zabielska, A., Johnson, M. L., Schimke, J. M., Jakaitis, D. R., Lebrasseur, N. K., Jensen, M. D., Sreekumaran Nair, K., & Zabielski, P. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00584.2012 · Cited by 135 · cited 2×
“mRNA expression of insulin-stimulated glucose transporter4 (GLUT4), insulin receptor substrate-1 (IRS1), and glycogen synthase-1 (GYS1) (35).”
BackgroundHabitual intake of flavonoid subclasses and risk of colorectal cancer in 2 large prospective cohorts
Nimptsch, K., Zhang, X., Cassidy, A., Song, M., O’Reilly, É. J., Lin, J. H., Pischon, T., Rimm, E. B., Willett, W. C., Fuchs, C. S., et al. (2016) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.115.117507 · Cited by 103
Yang, K., Zeng, L., Bao, T., & Ge, J. (2018) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-018-0346-x · Cited by 103
Aas, V., Rokling-Andersen, M. H., Kase, E. T., Thoresen, G. H., & Rustan, A. C. (2006) · Journal of Lipid Research · doi:10.1194/jlr.m500300-jlr200 · Cited by 101 · cited 1×
“(42) found that glucose transport and oxidation (CO2) in muscle cells were increased by 2-folds and the glucose transporter-1 (GLUT1) expression was increased by 2.”
BackgroundThe Effect of Marine Derived n-3 Fatty Acids on Adipose Tissue Metabolism and Function
Todorčević, M., & Hodson, L. (2015) · Journal of Clinical Medicine · doi:10.3390/jcm5010003 · Cited by 95
Serum Fatty Acids and Incidence of Ischemic Stroke Among Postmenopausal Women
Yaemsiri, S., Sen, S., Tinker, L. F., Robinson, W. R., Evans, R. W., Rosamond, W., Wasserthiel-Smoller, S., & He, K. (2013) · Stroke · doi:10.1161/strokeaha.111.000834 · Cited by 81
Regidor, P., Mueller, A., Sailer, M., Santos, F. G., Rizo, J. M., & Egea, F. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010384 · Cited by 76
Mirmasoumi, G., Fazilati, M., Foroozanfard, F., Vahedpoor, Z., Mahmoodi, S., Taghizadeh, M., Esfeh, N. K., Mohseni, M., Karbassizadeh, H., & Asemi, Z. (2018) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-119751 · Cited by 64
Sadeghi, A., Djafarian, K., Mohammadi, H., & Shab‐Bidar, S. (2016) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2016.06.025 · Cited by 58
Félix-Soriano, E., Martínez-Gayo, A., Cobo, M. J., Pérez-Chávez, A., Ibáñez-Santos, J., Palacios Samper, N., Goikoetxea Galarza, I., Cuervo, M., García-Unciti, M., González-Muniesa, P., et al. (2021) · Nutrients · doi:10.3390/nu13072465 · Cited by 50
Assessment of insulin resistance in young women with polycystic ovary syndrome
Jensterle, M., Weber, M., Pfeifer, M., Prezelj, J., Pfutzner, A., & Janez, A. (2008) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2008.03.017 · Cited by 43
Current and future aspects of several adjunctive treatment strategies in polycystic ovary syndrome
Banaszewska, B., Pawelczyk, L. A., & Spaczyński, R. (2019) · Reproductive Biology · doi:10.1016/j.repbio.2019.09.006 · Cited by 42
Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
Nardo, L. G., Patchava, S. D., & Laing, I. (2008) · PubMed · Cited by 41
Gao, H. Y., Meng, J., Xu, M., Zhang, S., Bishwajit, G., Liu, J., Yao, P., Yan, H., Wang, D., & Liu, L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067727 · Cited by 35
N-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications
Salek, M., Clark, C. C. T., Taghizadeh, M., & Jafarnejad, S. (2019) · EXCLI journal · doi:10.17179/excli2019-1534 · Cited by 34
Rodríguez‐Cruz, M., Atilano-Miguel, S., Barbosa-Cortés, L., Bernabé-García, M., Almeida‐Becerril, T., Cárdenas‐Conejo, A., Cruz‐Guzmán, O. D. R., & Maldonado‐Hernández, J. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.10.017 · Cited by 32
Galazis, N., Afxentiou, T., Xenophontos, M., Diamanti‐Kandarakis, E., & Atiomo, W. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0718 · Cited by 31
Effects of omega-3 supplementation on body weight and body fat mass: A systematic review
Delpino, F. M., Figueiredo, L. M., & da Silva, B. G. C. (2021) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2021.04.023 · Cited by 31
Luo, X., Jia, R., Yao, Q., Xu, Y., Luo, Z., Luo, X., & Wang, N. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500714 · Cited by 30
Self-citationIsanejad, M., Tajik, B., McArdle, A., Tuppurainen, M. T., Sirola, J. P., Kröger, H., Rikkonen, T., & Erkkilä, A. T. (2021) · European Journal of Nutrition · doi:10.1007/s00394-021-02773-z · Cited by 30
Razny, U., Kiec-Wilk, B., Polus, A., Goralska, J., Malczewska-Malec, M., Wnek, D., Zdzienicka, A., Gruca, A., Childs, C. E., Kapusta, M., et al. (2015) · BBA Clinical · doi:10.1016/j.bbacli.2015.05.001 · Cited by 27
Dias, B. V., Gomes, S. V., Castro, M. L. D. C., Carvalho, L. C. F., Breguez, G. S., de Souza, D. M. S., Ramos, C. D. O., Sant’Ana, M. R., Nakandakari, S. C. B. R., Araújo, C. M., et al. (2022) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2022.106622 · Cited by 26
Is Insulin Resistance an Intrinsic Defect in Asian Polycystic Ovary Syndrome?
Lee, H., Oh, J. Y., Sung, Y., & Chung, H. (2013) · Yonsei Medical Journal · doi:10.3349/ymj.2013.54.3.609 · Cited by 23
Schweitzer, G. R. B., Rios, I. N. M. S., Gonçalves, V. S. S., Magalhães, K. G., & Pizato, N. (2021) · Journal of Nutritional Science · doi:10.1017/jns.2021.46 · Cited by 22
Dietary and serum n -3 PUFA and polycystic ovary syndrome: a matched case–control study
Lu, L., Li, X., Lv, L., Xu, Y., Wu, B., & Huang, C. (2022) · British Journal of Nutrition · doi:10.1017/s0007114521003007 · Cited by 20 · cited 3×
“Because gastrointestinal digestion and the absorption process of foods could affect the bioavailability and clinical efficacy of dietary omega-3 PUFAs, leading to the underestimation of their beneficial effects (24).”
BackgroundSelf-citation
Research works printed but not linked: 1
- Salek, 2019, Jafarnejad S. N-3 fatty acids as preventive and therapeutic agents in attenuating PCOS complications, EXCLI J., 18, 558
Cited by
n-3 PUFA Promotes Ferroptosis in PCOS GCs by Inhibiting YAP1 through Activation of the Hippo Pathway
Zhang, P., Pan, Y., Wu, S., He, Y., Wang, J., Chen, L., Zhang, S., Zhang, H., Zhao, Y., Niu, L., et al. (2023) · Nutrients · doi:10.3390/nu15081927 · Cited by 35
Therapeutic Potential of Olive Leaf Extracts: A Comprehensive Review
de Oliveira, N. M., Machado, J. P., Chéu, M. H., Lopes, L. T., & Criado, M. B. (2024) · Applied Biosciences · doi:10.3390/applbiosci3030026 · Cited by 43
Role of Omega-3 Fatty Acids in Improving Metabolic Dysfunctions in Polycystic Ovary Syndrome
Albardan, L., Platat, C., & Kalupahana, N. S. (2024) · Nutrients · doi:10.3390/nu16172961 · Cited by 18
“…included 185 women with PCOS from China, found that both dietary n -3 PUFA intake as well as serum n -3 PUFA, especially EPA and DHA levels, were negatively correlated with HOMA-IR index and body fat levels [63], suggesting that n -3 PUFA may help in improving insulin resistance among these women.”
BackgroundShao, F., Xu, S., Zhao, H., Zhang, F., Wang, X., & Wang, H. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1420004 · Cited by 8
Fisberg, M., Batista, L. D., Previdelli, Á. N., Ferrari, G., & Fisberg, R. M. (2024) · Nutrients · doi:10.3390/nu16050750 · Cited by 10
Metadata
- Authors
- Lu, L., Li, X., Lv, L., Xu, Y., Wu, B., & Huang, C.
- Affiliations
- First Affiliated Hospital of Chengdu Medical College (CN)
- Guangdong Provincial People's Hospital (CN)
- Corresponding author
- Lu, Ling
- Venue
- Frontiers in Nutrition
- Publisher
- Frontiers Media SA
- Published
- 2022-10-05
- Volume
- 9
- Pages
- 1016943-1016943
- ISSN
- 2296-861X (ISSN-L)
- PMC
- PMC9581053
- OpenAlex
- W4301394269
- Cited by
- 22
- References
- 45
- Citations by year
- 2026: 8 · 2025: 5 · 2024: 6 · 2023: 3
- FWCI
- 2.95
- Type
- journal article
- Language
- en
- Update notices
- corrigendum (2024-03-01)
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Nutrition (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Natural Science Foundation of Xinjiang
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- polycystic ovary syndrome, omega-3 fatty acids, long-chain polyunsaturated fatty acids, insulin resistance, HOMA-IR, body composition, fat mass, muscle mass, eicosapentaenoic acid, docosahexaenoic acid, dietary intake, serum biomarkers, women's health, cardiometabolic risk, abdominal obesity, DPA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.